Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial by Home, Philip D, Prof, Pocock, Stuart J, Prof, Beck-Nielsen, Henning, Prof, Curtis, Paula S, PhD, Gomis, Ramon, Prof, Hanefeld, Markolf, Prof, Jones, Nigel P, MA, Komajda, Michel, Prof, McMurray, John JV, Prof

Get full text

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) S... by Erdmann, Erland, Dormandy, John A, Charbonnel, Bernard, Massi-Benedetti, Massimo, Moules, Ian K, Skene, Allan M

Get full text

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study by Pfister, R., Cairns, R., Erdmann, E., Schneider, C. A.

Get full text

Quality of service provision for anticoagulation in atrial fibrillation. In Finland anticoagulant treatment is monitored by general practitioners by Eskola, K, Virjo, I, Isokoski, M, Aittobiemi, P, Kurunmäki, H, Latva-Nevala, A, Paloneva, M, Wallin, A M, Viitaniemi, M, Ylinen, S

Get full text

In Finland anticoagulant treatment is monitored by general practitioners by Eskola, K, Virjo, I, Isokoski, M, Aittobiemi, Pirjo, Kurunmaki, H, Latva-Nevala, A, Paloneva, M, Wallin, A-M, Viitaniemi, M, Ylinen, S, Ohman, S

Get full text

Quality of service provision for anticoagulation in atrial fibrillation by Edwards, Adrian, Pill, Roisin, Lip, Gregory Y. H., Scott, Michael E., Wallace, William F. M., Marshall, Tom, Davis, R. C., Eskola, K., Virjo, I., Isokoski, M., Aittobiemi, Pirjo, Kurunmǎki, H., Latva-Nevala, A., Paloneva, M., Wallin, A.-M., Viitaniemi, M., Ylinen, S., Öhman, S.

Get full text

S73: Visual mismatch negativity to changes in facial expressions in depressed and control participants by Astikainen, P, Latva-Nevala, E, Cong, F

Get full text